.jpg)
About Burnet
At Burnet, everything we do is focused on making a sustainable difference to people’s health, in Australia and around the world.
The Burnet Institute is named in honour of Sir Frank Macfarlane Burnet who received the Nobel Prize for Medicine in 1960. Over the last 25 years the Institute has developed into one of Australia's leading Australian medical research and public health organisations. Its mission is to address the major health challenges of disadvantaged, marginalised and resource-poor groups in Australia and overseas.
Burnet’s culture links innovative discovery-oriented research with development and humanitarian action. We integrate our world-class laboratory and field-based research into multidisciplinary programs to prevent, detect and treat diseases of global significance. This unique approach allows us to make a tangible and sustainable impact on health in both developed and developing countries.
The medical research programs conducted in our Australian laboratories encompass three areas: infectious diseases – hepatitis, HIV, influenza, malaria and tuberculosis; cancers – breast, ovarian, prostate and blood cancers; and autoimmune diseases: rheumatoid arthritis and lupus. We undertake innovative epidemiological research, including surveillance and modelling complemented by participatory social research.
We work at international and regional levels, and with governments, civil society and communities in more than 15 countries. We build capacity and strengthen health services to reduce the impact of major health problems. Some of these include: reducing the impact and spread of HIV, promoting sexual and reproductive health, and improving the health of children, youth, parents and older people.
Burnet comprises four Centres – Virology, Immunology, Population Health and International Health. These Centres represent our key areas of research and public health.
Burnet is also home to the WHO Regional HIV Drug Resistance Laboratory - Asia Pacific Region and the Burnet ImmunoMonitoring Facility (IMF).
 |  |  |